Cybin Inc. (NEO:CYBN)
Canada
· Delayed Price · Currency is CAD 11.15
+0.35 (3.24%)
Jul 4, 2025, 3:59 PM EDT
Cybin Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
50
Market Cap
248.11M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sienna Senior Living | 896.45M |
| Green Thumb Industries | 1.64B |
| dentalcorp Holdings | 1.58B |
| Extendicare | 1.47B |
| WELL Health Technologies | 990.34M |
| Cronos Group | 179.08M |
| Trulieve Cannabis | 1.71B |
| Curaleaf Holdings | 1.89B |
Cybin News
- 5 days ago - REPEAT/Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures - Business Wire
- 5 days ago - Cybin reports Q4 results - Seeking Alpha
- 5 days ago - Cybin Reports Fiscal Year 2025 Financial Results and Recent Business Highlights - Business Wire
- 5 days ago - Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures - Business Wire
- 23 days ago - Cybin Provides Corporate Update and Highlights Positive Regulatory Signals for Psychedelic Therapeutics - Business Wire
- 24 days ago - Cybin to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Conference - Business Wire
- 25 days ago - Cybin to Participate in the 2025 Psychedelic Science Conference - Business Wire
- 4 weeks ago - Cybin Announces Additional U.S. Patent Supporting its CYB004 Program in Phase 2 Development for Generalized Anxiety Disorder - Business Wire